Australia

Social media shares drop $ 233 billion in one day as Snapchat becomes canary in coal mine

Shares of social media on Wall Street lost $ 165 billion ($ 233 billion) in one-day trading after a disastrous earnings warning from Snapchat’s parent company. Shares of Snap fell more than 40 percent on Tuesday and reached their lowest level since March 2020, just after the COVID-19 pandemic hit the United States. The company …

Social media shares drop $ 233 billion in one day as Snapchat becomes canary in coal mine Read More »

Johnson faces new leadership speculation amid a scathing report on alcohol culture

Loading Johnson will address the House of Commons at 12.30pm GMT and is expected to address his own MPs later Wednesday to try to rally the troops as new questions about his leadership accumulate. The investigation into the heartbreaks of the British government in Whitehall was commissioned in mid-January, but was later delayed to allow …

Johnson faces new leadership speculation amid a scathing report on alcohol culture Read More »

Please enable JavaScript and reload the page. Please check your browser before going to onlinelibrary.wiley.com.

Prevalence of reactive immunoglobulin A antibodies in saliva with severe acute respiratory syndrome Coronavirus 2 among Japanese not exposed to John Wiley virus Study investigates associations between antibody response to COVID-19 vaccination and risk of subsequent infection News-Medical.Net Antibody and seroprevalence response in healthcare workers after BNT162b2 vaccination at Tokyo University Hospital | Nature.com scientific …

Please enable JavaScript and reload the page. Please check your browser before going to onlinelibrary.wiley.com. Read More »

Efficacy of sotrovimab versus molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

In a recent study published on the medRxiv * prepress server, researchers compared the effectiveness of sotrovimab [an intravenously administered neutralizing monoclonal antibody (nMAb)] and molnupiravir (an orally administered antiviral drug) to prevent the serious outcomes of coronavirus 2019 (COVID-19) among non-hospitalized and high-risk patients with COVID-19 across England. Study: Comparative efficacy of sotrovimab and …

Efficacy of sotrovimab versus molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients Read More »

Moscow wants to bring Donetsk and Luhansk under control, Ukraine claims the enemy killed 14 civilians

Russian forces tried to encircle Ukrainian troops in twin cities east of a river while President Volodymyr Zelenskyi warned that Moscow was trying to destroy the industrial region of the Donbas where it has focused its attacks. Key points: When the invasion of Ukraine enters its fourth month, Russia concentrates on the east Russia is …

Moscow wants to bring Donetsk and Luhansk under control, Ukraine claims the enemy killed 14 civilians Read More »

Efficacy of molnupiravir and nirmatrelvir / ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

In a recent study published in Preprints with The Lancet *, researchers evaluated the effectiveness of two orally administered antiviral drugs, nirmatrelvir / ritonavir and molnupiravir, to reduce hospitalization and deaths among the world’s outpatient coronavirus disease. real 2019 (COVID-19) patients in Hong Kong. Study: Impact of the use of oral antiviral agents on the …

Efficacy of molnupiravir and nirmatrelvir / ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients Read More »

Efficacy of molnupiravir and nirmatrelvir / ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

In a recent study published in Preprints with The Lancet *, researchers evaluated the effectiveness of two orally administered antiviral drugs, nirmatrelvir / ritonavir and molnupiravir, to reduce hospitalization and deaths among the world’s outpatient coronavirus disease. real 2019 (COVID-19) patients in Hong Kong. Study: Impact of the use of oral antiviral agents on the …

Efficacy of molnupiravir and nirmatrelvir / ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients Read More »